Table 1.

FAK expression in ESCS before and after treated by ovarian steroid hormones

Group	n	None	E + P	P
EM	15	0.221 ± 0.009	0.226 ± 0.006a	0.022 ± 0.011b
Control	17	0.191 ± 0.011	0.196 ± 0.012c	0.193 ± 0.007d

^a P > 0.05, compared with FAK expression before treated by ovarian steroid hormones;

^b P > 0.05, compared with FAK expression before treated by ovarian steroid hormones;

^c P > 0.05, compared with FAK expression before treated by ovarian steroid hormones.

^d P > 0.05, compared with FAK expression before treated by ovarian steroid hormones.